Hemispherix BioPharma
(NYSE: HEB)
CEO: Tom Equels
THIS INTERVIEW HAS EXPIRED
Hemispherix BioPharma
(NYSE: HEB)
CEO: Tom Equels
THIS INTERVIEW HAS EXPIRED
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com